Skip to main content
. Author manuscript; available in PMC: 2010 Nov 23.
Published in final edited form as: Vaccine. 2009 Sep 26;27(50):7087–7095. doi: 10.1016/j.vaccine.2009.09.059

Table 1.

HIV-derived CTL epitopes used in vaccine design and synthesis

HLA-A2 Epitopes HLA-A3 Epitopes HLA-B7 Epitopes
Protein Designation1 Amino Acid Sequence1 Protein Designation Amino Acid Sequence Protein Designation Amino Acid Sequence
Pol 498 ILKEPVHGV Env 47 VTVYYGVPVWK Nef 94 FPVRPQVPL
Gag 386 VLAEAMSQV Pol 929 QMAVFIHNFK Gag 545 YPLASLRSLF
Pol 448 KLVGKLNWA Pol 98 VTIKIGGQLK Rev 75 VPLQLPPL
Env 134 KLTPLCVTL Pol 971 KIQNFRVYYR Env 259 IPIHYCAPA
Vpr 62 RILQQLLFI Pol 347 AIFQSSMTK Gag 237 HPVHAGPIA
Nef 221 LTFGWCFKL Pol 722 KVYLAWPAHK Pol 893 IPYNPQSQGW
Gag 271 MTNNPPIPV Env 61 TTLFCASDAK Env 250 CPKVSFEPI
1

Epitopes are designed based on their location within HIV viral gene products using gene name and the position of the first amino acid using an internal consensus sequence specific for the data base used. Sequences are shown using the single letter amino acid designations.